Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-21

Clinical Trial Update: Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

View source ↗

Summary

This clinical trial update describes research into the nociceptin/orphanin FQ receptor as a potential target for major depressive disorder and notes that the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mclean Hospital | Conditions: Major Depressive Disorder | Status: RECRUITING